Efficacy and Safety of Pembrolizumab Added to Azacitidine Plus Venetoclax for Patients with Acute Myeloid Leukemia: Results from an Investigator-Initiated, Multi-Center, CTEP-Sponsored Randomized, Phase II Trial (BLAST AML-2)

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Blood

Topics

Cancer Oncology

Internal Medicine

Hematology

Biology

Cancer Oncology

Medicine

Internal Medicine

Hematology

Show all topics

DOI

10.1182/blood-2024-210370